Franz Kerdel, DO is a native of South Florida. He received an undergraduate degree in Biology at the University of Miami. After graduating from the University of Miami, he went on to obtain a Masters in Biomedical Sciences from Barry University. He attended medical school at Nova Southeastern University. He completed a Traditional Rotating Internship and is currently a dermatology resident in his third year at Larkin Community Hospital. After graduating he plans on practicing dermatology in South Florida.
Medical Dermatology Update
This lecture will introduce basic approaches to complex medical dermatology with specific diseases being reviewed.
- How to manage and identify complex medical dermatology cases
- Learn various presentations and variations of skin conditions
- New treatments on the horizon
- Review histopathology of unique and difficult cases
- Explore different treatment options for difficult to manage cases
- Diagnosis and pathophysiology of select diseases
- New advances in dermatologic treatment
- Availability of new medication(s) and indication(s)
- Advances in medical knowledge
- New methods of diagnosis or treatment
- Development of new technology
- Legislative, regulatory, or organizational changes effecting patient care
- Bolognia, Jean L., et al. “Dermatology” Section 4, Chapter 20, pg 323-332. Mosby Elsevier. 2008.
- Chong, Huey Ti, et al. “Cost-Effectiveness analysis of HLA-B*58”. Pharmacogenetics and Genomics, 2017, p. 1, doi:10.1097/fpc.0000000000000319.
- Bolognia 2nd edition, North, Paula E, Kincannon, Jay. Section 18, Chapter 114, pg. 1788.
- Weedon’s Skin Pathology, Weedon, David. Section 7, Chapter 38, pg. 920.
- Bolognia 2nd Edition – Section 7/42, pg. 583.
- Carter, A., Orgega-Loayza, AG., Barrett, J., Nunley, J., “Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: a multidisciplinary approach”. Clinical and Experimental Dermatology. Doi:10.1111/ced.12729.
- Speeckaert MM, Devreese KMJ, Vanholder RC, Dhondt A. “Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients”. Nephrology Dialysis Transplantation. 2013;28(12):3090-3095. Doi:10.1093/ndt/gft293.
Core Competencies: 1, 2, 3, 4, 6, 7
Disclosures: No disclosures provided by speaker